Swiss National Bank
KITE

Swiss National Bank’s Kite Pharma, Inc. KITE Stock Holding History

Swiss National Bank’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-83,385
Closed -$15M – 2588
2017
Q3 		$15M Buy
83,385
+6,435
+8% +$897K 0.02% 618
2017
Q2 		$7.98M Hold
76,950
– – 0.01% 759
2017
Q1 		$6.04M Buy
76,950
+11,700
+18% +$723K 0.01% 879
2016
Q4 		$2.93M Buy
65,250
+1,700
+3% +$83.4K ﹤0.01% 1306
2016
Q3 		$3.55M Sell
63,550
-400
-0.6% -$22.3K 0.01% 1137
2016
Q2 		$3.2M Buy
63,950
+1,300
+2% +$63.9K 0.01% 1164
2016
Q1 		$2.78M Buy
62,650
+14,800
+31% +$717K 0.01% 1230
2015
Q4 		$2.95M Buy
47,850
+10,500
+28% +$739K 0.01% 1080
2015
Q3 		$2.08M Buy
37,350
+5,400
+17% +$340K 0.01% 1280
2015
Q2 		$1.95M Sell
31,950
-1,300
-4% -$74.2K 0.01% 1321
2015
Q1 		$1.92M Buy
33,250
+2,300
+7% +$154K 0.01% 1318
2014
Q4 		$1.78M Buy
+30,950
New +$1.3M 0.01% 1337

Swiss National Bank's KITE Position: Q4 2017 in Review

Swiss National Bank sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 83,385 shares — an estimated $15M sold.

Swiss National Bank first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $15M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Swiss National Bank reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Swiss National Bank sold 83,385 Kite Pharma, Inc. shares in Q4 2017, an estimated $15M.
  • Swiss National Bank first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
  • Swiss National Bank's Kite Pharma, Inc. position peaked at $15M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Swiss National Bank's 13F filing for Q4 2017, filed 7 Feb 2018.